Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

SNSESNSE
5 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in FAETH THERAPEUTICS INC

Yes. BNP Paribas Financial Markets holds 113 shares of SNSE (Faeth Therapeutics), worth $2,825, as of its Q2 2026 13F filing. It increased the position from 9 shares in Q1 2026. BNP Paribas Financial Markets has held SNSE since Q2 2025, across 5 quarterly 13F filings.

Current Value

$2,825

Current Shares

113

Total Value Change

+$2,748

Total Shares Change

+104

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
113
+1155.6%
$2,8250.0%$25.00
14
2026-Q1
Unchanged
9
0.0%
$2840.0%$31.52
0
2025-Q4
Unchanged
9
0.0%
$960.0%$10.67
0
2025-Q3
Unchanged
9
0.0%
$850.0%$9.45
0
2025-Q2
New
9
-
$770.0%$8.58
17

Other major holders of SNSE: Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, BALYASNY ASSET MANAGEMENT L.P., RA CAPITAL MANAGEMENT, L.P., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used